Decibel Therapeutics Inc. (DBTX)

AI Score

Unlock

4.91

-0.04 (-0.81%)

At close: Sep 22, 2023, 8:00 PM

4.91

0.00%

After-hours: Sep 22, 2023, 04:11 PM EDT

Decibel Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019
Period Ending	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-66M	-64.06M	-63.96M	-60.37M	-58.72M	-53.35M	-50.23M	-50.34M	-42.72M	-38.85M	-39.56M	-32.99M	-25.9M	-18.05M	-6.44M
Interest Income	2.89M	2.01M	1.19M	584K	243K	223K	193K	93K	62K	9K	55K	320K	318K	296K	217K
Pretax Income	-63.11M	-62.05M	-62.77M	-59.78M	-58.47M	-53.11M	-50.03M	-50.07M	-42.52M	-38.67M	-39.34M	-32.67M	-25.56M	-17.75M	-6.22M
Net Income	-63.39M	-62.29M	-63.01M	-59.97M	-60.36M	-54.97M	-51.82M	-51.8M	-42.52M	-38.67M	-39.34M	-32.67M	-25.56M	-17.75M	-6.22M
Selling & General & Admin	23.61M	23.26M	23.63M	23.66M	23.02M	22.05M	20.38M	20.57M	17.29M	14.95M	14.24M	12.39M	9.99M	7.44M	3.26M
Research & Development	42.38M	40.8M	40.33M	36.72M	35.71M	31.29M	29.85M	29.76M	25.43M	23.91M	25.32M	20.6M	15.91M	10.61M	3.17M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-25K	n/a	n/a	n/a	25K	n/a	n/a
Operating Expenses	66M	64.06M	63.96M	60.37M	58.72M	53.35M	50.23M	50.34M	42.72M	38.85M	39.56M	32.99M	25.9M	18.05M	6.44M
Interest Expense	1.03M	1.13M	1.13M	469K	95K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	66M	64.06M	63.96M	60.37M	58.72M	53.35M	50.23M	50.34M	42.72M	38.85M	39.56M	32.99M	25.9M	18.05M	6.44M
Income Tax Expense	283K	241K	240K	193K	1.9M	1.86M	1.8M	1.39M	-347K	-369K	-369K	-24K	-22K	n/a	n/a
Shares Outstanding (Basic)	25.02M	24.99M	24.96M	24.96M	24.96M	24.96M	24.95M	24.87M	24.87M	12.11M	23.12M	7.36M	7.36M	7.36M	7.36M
Shares Outstanding (Diluted)	25.02M	24.99M	24.96M	24.96M	24.96M	24.96M	24.95M	24.87M	24.87M	12.11M	23.12M	7.36M	7.36M	7.36M	7.36M
EPS (Basic)	-2.54	-2.49	-2.52	-2.4	-2.42	-2.21	-2.55	-2.59	-2.9	-3.49	-4.16	-4.45	-3.48	-2.42	-0.85
EPS (Diluted)	-2.54	-2.49	-2.52	-2.4	-2.42	-2.21	-2.55	-2.59	-2.9	-3.49	-4.16	-4.45	-3.48	-2.42	-0.85
EBITDA	-64.6M	-62.62M	-62.49M	-58.98M	-57.35M	-51.99M	-48.82M	-49.23M	-41.57M	-37.62M	-38.27M	-31.14M	-24.45M	-17.01M	-5.88M
EBIT	-44.77M	-61.68M	-47.68M	-32.51M	-16.91M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	1.4M	1.44M	1.46M	1.4M	1.38M	1.35M	1.41M	1.45M	1.5M	1.58M	1.64M	1.85M	1.46M	1.04M	554K